These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 9072003)
1. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations. Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003 [TBL] [Abstract][Full Text] [Related]
2. MDM2 and p21WAF1/CIP1, wild-type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease. Sánchez-Beato M; Piris MA; Martínez-Montero JC; García JF; Villuendas R; García FJ; Orradre JL; Martínez P J Pathol; 1996 Sep; 180(1):58-64. PubMed ID: 8943816 [TBL] [Abstract][Full Text] [Related]
3. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma. Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040 [TBL] [Abstract][Full Text] [Related]
4. The pattern of p53 and p21WAF1/CIP1 immunoreactivity in non-Hodgkin's lymphomas predicts p53 gene status. Mansukhani MM; Osborne BM; Zhong J; Matsushima AY Diagn Mol Pathol; 1997 Aug; 6(4):222-8. PubMed ID: 9360843 [TBL] [Abstract][Full Text] [Related]
5. Expression of p53, MDM2, p21waf1, bcl-2, and retinoblastoma gene proteins in myelodysplastic syndrome after autologous bone marrow transplantation for lymphoma. Brynes RK; Wilson CS; Kim AB; McCourty A Mod Pathol; 1997 Nov; 10(11):1120-7. PubMed ID: 9388063 [TBL] [Abstract][Full Text] [Related]
6. p53 gene status and expression of p53, mdm2, and p21Waf1/Cip1 proteins in colorectal cancer. Veloso M; Wrba F; Kaserer K; Heinze G; Magalhães A; Herbst F; Teleky B Virchows Arch; 2000 Sep; 437(3):241-7. PubMed ID: 11037343 [TBL] [Abstract][Full Text] [Related]
7. Expression of p21waf1/Cip1, MDM2 and p53 in vivo: analysis of cytological preparations. Dowell SP; McGoogan E; Picksley SM; el-Deiry WS; Vogelstein B; Hall PA Cytopathology; 1996 Oct; 7(5):340-51. PubMed ID: 8911758 [TBL] [Abstract][Full Text] [Related]
8. p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function. Chilosi M; Doglioni C; Magalini A; Inghirami G; Krampera M; Nadali G; Rahal D; Pedron S; Benedetti A; Scardoni M; Macrì E; Lestani M; Menestrina F; Pizzolo G; Scarpa A Blood; 1996 Nov; 88(10):4012-20. PubMed ID: 8916968 [TBL] [Abstract][Full Text] [Related]
9. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods. Lu ML; Wikman F; Orntoft TF; Charytonowicz E; Rabbani F; Zhang Z; Dalbagni G; Pohar KS; Yu G; Cordon-Cardo C Clin Cancer Res; 2002 Jan; 8(1):171-9. PubMed ID: 11801555 [TBL] [Abstract][Full Text] [Related]
10. MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue. Comparative study with p53 expression. Martinez JC; Mateo M; Sánchez-Beato M; Villuendas R; Orradre JL; Algara P; Sánchez-Verde L; García P; López C; Martínez P J Pathol; 1995 Sep; 177(1):27-34. PubMed ID: 7472776 [TBL] [Abstract][Full Text] [Related]
11. p21WAF1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx. Nadal A; Jares P; Cazorla M; Fernández PL; Sanjuan X; Hernandez L; Pinyol M; Aldea M; Mallofré C; Muntané J; Traserra J; Campo E; Cardesa A J Pathol; 1997 Oct; 183(2):156-63. PubMed ID: 9390027 [TBL] [Abstract][Full Text] [Related]
12. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation. Jin Y; Lee H; Zeng SX; Dai MS; Lu H EMBO J; 2003 Dec; 22(23):6365-77. PubMed ID: 14633995 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of p21WAF1/CIP1 and MDM2 characterizes serous borderline ovarian tumors. Palazzo JP; Monzon F; Burke M; Hyslop T; Dunton C; Barusevicius A; Capuzzi D; Kovatich AJ Hum Pathol; 2000 Jun; 31(6):698-704. PubMed ID: 10872663 [TBL] [Abstract][Full Text] [Related]
15. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708 [TBL] [Abstract][Full Text] [Related]
16. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue. Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P Anticancer Res; 1998; 18(4A):2403-8. PubMed ID: 9703886 [TBL] [Abstract][Full Text] [Related]
17. p53 expression in CMV-infected cells: association with the alternative expression of the p53 transactivated genes p21/WAF1 and MDM2. García JF; Piris MA; Lloret E; Orradre JL; Murillo PG; Martínez JC Histopathology; 1997 Feb; 30(2):120-5. PubMed ID: 9067734 [TBL] [Abstract][Full Text] [Related]
18. Expression of p53 and p21WAF1/CIP1 proteins in gastric and esophageal cancers: comparison with mutations of the p53 gene. Seta T; Imazeki F; Yokosuka O; Saisho H; Suzuki T; Koide Y; Isono K Dig Dis Sci; 1998 Feb; 43(2):279-89. PubMed ID: 9512119 [TBL] [Abstract][Full Text] [Related]
19. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma. Møller MB; Nielsen O; Pedersen NT Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214 [TBL] [Abstract][Full Text] [Related]